The Health Care Trust seeks to maximize total return through capital appreciation with a econdary objective of current income.
|Mandatory Maturity Date||7/28/2010|
|NASDAQ Ticker Symbol||CHCRHX|
|Inception Unit Price||$10.0000|
|Maturity Price (as of 7/28/10)||$7.9935|
|Historical Annual Dividend Distribution*||$0.0925|
* The Historical Annual Dividend Distribution is as of the date of deposit and subject to change. The amount of distributions paid by the Trust’s securities may be lower or greater than the above-stated amount due to certain factors that may include, but are not limited to, a change in the dividends paid by issuers, a change in Trust expenses or the sale or maturity of securities in the portfolio. Fees and expenses of the Trust may vary as a result of a variety of factors including the Trust’s size, redemption activity, brokerage and other transaction costs and extraordinary expenses.
Past performance is no guarantee of future results. Investment returns and principal value will fluctuate with changes in market conditions. Investors' units, when redeemed, may be worth more or less than their original cost.
This information does not constitute an offer to sell or a solicitation of any offer to buy: nor shall there be any sale of these securities in any state where the offer, solicitation, or sale is not permitted.
Principal Investment Strategy
The trust consists of 40 stocks classified as being in the Health Care Sector by the Global Industry Classification Standard (“GICS”). The trust is diversified across the Health Care Sector, which includes the following industries:
Biotechnology, Health Care Equipment and Supplies, Health Care Providers and Services, Life Sciences Tools and Services, and Pharmaceuticals. The sponsor selects stocks for the portfolio that it believes have the potential to achieve the trust’s investment objective.
The sponsor selects U.S.-traded stocks that it believes are core holdings of a well-diversified health care portfolio. To select the portfolio, the sponsor follows a very disciplined process that includes both quantitative and qualitative analysis. The sponsor begins with the approximately 550 stocks of companies that are classified as being in the Health Care Sector, traded on U.S. exchanges, and are either components of the Russell 3000 Index (“R3K”) or have market capitalizations larger than the smallest company within the R3K. The sponsor then reduces the size of this universe to approximately 250 stocks by performing quantitative screening, which may be primarily based on, but not limited to, the following factors:
The sponsor then reduces the 250 securities to 40 stocks by performing qualitative analysis, which may be primarily based on, but not limited to, the following factors:
The Russell 3000® Index
The Russell 3000® Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization, which represents approximately 98% of the investable U.S. equity market. As of the latest reconstitution, the average market capitalization was approximately $5.1 billion; the median market capitalization was approximately $1.09 billion. The index had a total market capitalization range of approximately $368.5 billion to $218.4 million.
Risks and Other Considerations
As with all investments, you can lose money by investing in this trust. The trust also might not perform as well as you expect. This can happen for reasons such as these:
See “Investment Risks” in Part A of the prospectus and “Risk Factors” in Part B of the prospectus for additional information.
Please see the Trust prospectus for more complete risk information.
Unit Investment Trusts are fixed, not actively managed and should be considered as part of a long-term strategy. Investors should consider their ability to invest in successive portfolios, if available, at the applicable sales charge. UITs are subject to annual fund operating expenses in addition to the sales charge. Investors should consult an attorney or tax advisor regarding tax consequences associated with an investment from one series to the next, if available, and with the purchase or sale of units. Guggenheim Funds Distributors, LLC does not offer tax advice.
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the investment management business of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investments Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisors to the referenced funds.
© 2019 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.